Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Syneos | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Syneos

Combined Company (INC Research and inVentiv Health) brings in $1.1B in revenues

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Syneos
2Q Revenues: $1.1 billion (+174%)
2Q Earnings: $13.6 million (earnings were $3.4 million 2Q17)
YTD Revenues: $2.13 billion (+176%)
YTD Loss: $11.0 million (earnings were $24.6 million YTD17)
Comments: Combined Company (INC Research and inVentiv Health) net new business awards were $1.06 billion for the three months ended June 30, 2018, representing book-to-bill ratio of 1.32x. Clinical Solutions segment awards were $849.9 million in the quarter, resulting in book-to-bill ratio of 1.52. Awards grew 18.6% in the quarter. Commercial Solutions segment net awards were $205.8 million, representing  book-to-bill ratios of 0.86x for the quarter.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters